Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma
Closed
Other
This study is for people with melanoma who are going to have, or have had, treatment with a targeted cancer drug (biological therapy).
Targeted cancer drugs used to treat melanoma include:
ipilimumab (Yervoy)
nivolumab (Opdivo)
pembrolizumab (Keytruda)
vemurafinib (Zelboraf)
dabrafenib (Tafinlar)
Recruitment start: 13 October 2016
Recruitment end: 31 May 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Ms Janine Smedley
Cancer Research UK
Sheffield Teaching Hospitals NHS Foundation Trust
The University of Sheffield
Last reviewed: 30 May 2017
CRUK internal database number: 14631